BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

578 related articles for article (PubMed ID: 19394973)

  • 1. Inverse associations between muscle mass, strength, and the metabolic syndrome.
    Atlantis E; Martin SA; Haren MT; Taylor AW; Wittert GA;
    Metabolism; 2009 Jul; 58(7):1013-22. PubMed ID: 19394973
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of metabolic syndrome in HIV-infected patients receiving highly active antiretroviral therapy using International Diabetes Foundation and Adult Treatment Panel III criteria: associations with insulin resistance, disturbed body fat compartmentalization, elevated C-reactive protein, and [corrected] hypoadiponectinemia.
    Samaras K; Wand H; Law M; Emery S; Cooper D; Carr A
    Diabetes Care; 2007 Jan; 30(1):113-9. PubMed ID: 17192343
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimal threshold of homeostasis model assessment for insulin resistance in an Iranian population: the implication of metabolic syndrome to detect insulin resistance.
    Esteghamati A; Ashraf H; Esteghamati AR; Meysamie A; Khalilzadeh O; Nakhjavani M; Abbasi M
    Diabetes Res Clin Pract; 2009 Jun; 84(3):279-87. PubMed ID: 19359063
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence of metabolic syndrome and its relation to body composition in a Chinese rural population.
    Feng Y; Hong X; Li Z; Zhang W; Jin D; Liu X; Zhang Y; Hu FB; Wei LJ; Zang T; Xu X; Xu X
    Obesity (Silver Spring); 2006 Nov; 14(11):2089-98. PubMed ID: 17135627
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The metabolic syndrome and incidence of cardiovascular disease in non-diabetic subjects--a population-based study comparing three different definitions.
    Nilsson PM; Engström G; Hedblad B
    Diabet Med; 2007 May; 24(5):464-72. PubMed ID: 17381496
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lifestyle variables, non-traditional cardiovascular risk factors, and the metabolic syndrome in an Aboriginal Canadian population.
    Liu J; Young TK; Zinman B; Harris SB; Connelly PW; Hanley AJ
    Obesity (Silver Spring); 2006 Mar; 14(3):500-8. PubMed ID: 16648622
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating adipocyte-fatty acid binding protein levels predict the development of the metabolic syndrome: a 5-year prospective study.
    Xu A; Tso AW; Cheung BM; Wang Y; Wat NM; Fong CH; Yeung DC; Janus ED; Sham PC; Lam KS
    Circulation; 2007 Mar; 115(12):1537-43. PubMed ID: 17389279
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship between metabolic syndrome and its components with coronary heart disease in Iranian men and women.
    Zabetian A; Hadaegh F; Azizi F
    Exp Clin Endocrinol Diabetes; 2008 Oct; 116(9):525-31. PubMed ID: 18523915
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Demographic, physical and lifestyle factors associated with androgen status: the Florey Adelaide Male Ageing Study (FAMAS).
    Atlantis E; Martin SA; Haren MT; O'Loughlin PD; Taylor AW; Anand-Ivell R; Ivell R; Wittert GA;
    Clin Endocrinol (Oxf); 2009 Aug; 71(2):261-72. PubMed ID: 19178527
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The NCEP-ATPIII but not the IDF criteria for the metabolic syndrome identify Type 2 diabetic patients at increased risk of chronic kidney disease.
    Luk AO; Ma RC; So WY; Yang XL; Kong AP; Ozaki R; Ko GT; Chow CC; Cockram CS; Chan JC; Tong PC
    Diabet Med; 2008 Dec; 25(12):1419-25. PubMed ID: 19046240
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The association between pulse wave velocity and metabolic syndrome and adiponectin in patients with impaired fasting glucose: cardiovascular risks and adiponectin in IFG.
    Nam JS; Park JS; Cho MH; Jee SH; Lee HS; Ahn CW; Lowe WL; Kim KR
    Diabetes Res Clin Pract; 2009 May; 84(2):145-51. PubMed ID: 19261346
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum adiponectin confers little protection against diabetes and hypertension in Turkish men.
    Onat A; Hergenç G; Can G; Küçükdurmaz Z
    Obesity (Silver Spring); 2009 Mar; 17(3):564-70. PubMed ID: 19238142
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum complement C3: a determinant of cardiometabolic risk, additive to the metabolic syndrome, in middle-aged population.
    Onat A; Hergenç G; Can G; Kaya Z; Yüksel H
    Metabolism; 2010 May; 59(5):628-34. PubMed ID: 19913840
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of metabolic syndrome in the Mediterranean region of Turkey: evaluation of hypertension, diabetes mellitus, obesity, and dyslipidemia.
    Gündogan K; Bayram F; Capak M; Tanriverdi F; Karaman A; Ozturk A; Altunbas H; Gökce C; Kalkan A; Yazici C
    Metab Syndr Relat Disord; 2009 Oct; 7(5):427-34. PubMed ID: 19754305
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neck circumference as a measure of central obesity: associations with metabolic syndrome and obstructive sleep apnea syndrome beyond waist circumference.
    Onat A; Hergenç G; Yüksel H; Can G; Ayhan E; Kaya Z; Dursunoğlu D
    Clin Nutr; 2009 Feb; 28(1):46-51. PubMed ID: 19010573
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of individual components, time, and sex on prevalence of metabolic syndrome in adolescents.
    Daratha KB; Bindler RC
    Arch Pediatr Adolesc Med; 2009 Apr; 163(4):365-70. PubMed ID: 19349566
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risks of CHD identified by different criteria of metabolic syndrome and related changes of adipocytokines in elderly postmenopausal women.
    Ding QF; Hayashi T; Zhang XJ; Funami J; Ge L; Li J; Huang XL; Cao L; Zhang J; Akihisa I
    J Diabetes Complications; 2007; 21(5):315-9. PubMed ID: 17825756
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of leisure-time physical activity on the presence of metabolic syndrome in patients with manifest arterial disease. The SMART study.
    Brouwer BG; Visseren FL; van der Graaf Y;
    Am Heart J; 2007 Dec; 154(6):1146-52. PubMed ID: 18035088
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Waist circumference is the main determinant of elevated C-reactive protein in metabolic syndrome.
    Nakamura H; Ito H; Egami Y; Kaji Y; Maruyama T; Koike G; Jingu S; Harada M
    Diabetes Res Clin Pract; 2008 Feb; 79(2):330-6. PubMed ID: 17964679
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thyroid stimulating hormone is associated with metabolic syndrome in euthyroid postmenopausal women.
    Park HT; Cho GJ; Ahn KH; Shin JH; Hong SC; Kim T; Hur JY; Kim YT; Lee KW; Kim SH
    Maturitas; 2009 Mar; 62(3):301-5. PubMed ID: 19250778
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.